|
RSV Vaccine Available for Older Adults Later This Year
|
|
By this fall, older adults will likely be heading to their local pharmacy to be vaccinated against respiratory syncytial virus (RSV). The FDA recently approved the first vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 60 years or older. Find out more about this new vaccine, potential side effects, and availability.
|
|
|
Valproate Use in Expectant Mothers With Epilepsy
|
|
|
Pharmacists and other healthcare professionals were aware that valproate products should be used with caution in pregnant women. Now, a prospective, population-based register study published in the Journal of the American Medical Association Neurology heightens those concerns, reporting that 42% of children of mothers who used valproate during pregnancy developed a psychiatric disorder before age 18 years. Read more.
|
|
Novavax COVID-19 Vaccine Effective Against Hospitalization
|
|
|
When questioned about vaccine hesitancy, some adults say they do not want to get a COVID-19 vaccine because they want an effective option that is not novel mRNA technology. They have had an alternative since last summer, with the Novavax COVID-19 Vaccine, Adjuvanted, which was granted Emergency Use Authorization. Find out how effective the vaccine is in protecting adults against severe SARS-CoV-2.
|
|
|
Dexmedetomidine in Preventing Atrial Fibrillation Onset in ICU
|
|
Atrial fibrillation is the most common type of arrhythmia in patients with critical illness, and new onset in the ICU can cause adverse hemodynamic outcomes, systemic embolism, or stroke, resulting in worse clinical outcomes with longer ICU length of stay and higher mortality. A cohort study suggests that a widely used sedative might help combat the condition. Read more.
|
|
